financetom
Business
financetom
/
Business
/
Market Chatter: UBS' Swiss HQ 'Not Viable' Due to Country's Capital Plans, Activist Investor Cevian Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: UBS' Swiss HQ 'Not Viable' Due to Country's Capital Plans, Activist Investor Cevian Says
Sep 18, 2025 3:51 AM

06:40 AM EDT, 09/18/2025 (MT Newswires) -- UBS (UBS) has "no other realistic option" but to relocate its headquarters away from Switzerland, as the country's new strict capital proposals make it "not viable" to run a large international bank, the Financial Times reported on Thursday, quoting activist investor Cevian Capital as saying.

Cevian, which holds a 1.4% stake in UBS, said Swiss government proposals would require UBS to hold as much as $26 billion in extra capital, the report said.

"The message from the Federal Council is clear: UBS is too big for Switzerland... I respect the Federal Council's decision, but I do not understand it. It cannot be undone. Lobbyists cannot change that either. That effort can be spared," the FT quoted Lars Forberg, Cevian's co-founder, as saying.

UBS did not immediately respond to an MT Newswires request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biogen, Beckman Coulter, Fujirebio Partner for Potential Alzheimer's Blood Tests
Biogen, Beckman Coulter, Fujirebio Partner for Potential Alzheimer's Blood Tests
Jul 30, 2024
10:23 AM EDT, 07/30/2024 (MT Newswires) -- Biogen (BIIB), Beckman Coulter, and Fujirebio said Tuesday they are partnering to potentially develop blood-based biomarkers for detecting tau pathology in the brain of Alzheimer's disease patients. Financial details weren't disclosed. The companies said they aim to create minimally invasive tests to stratify patients and monitor treatment responses, potentially supporting the development of...
Extreme Networks, Intel Partner to Optimize Enterprise Network Performance
Extreme Networks, Intel Partner to Optimize Enterprise Network Performance
Jul 30, 2024
10:26 AM EDT, 07/30/2024 (MT Newswires) -- Extreme Networks ( EXTR ) said Tuesday it formed a co-innovation alliance with Intel ( INTC ) Connectivity Analytics program to improve native artificial intelligence capabilities within the Extreme AI Expert product. The collaboration will focus on supporting customers to optimize network performance, detect security threats, personalize end-user experiences and reduce operational costs,...
Nexstar Media, Paramount Renew Affiliation Contracts
Nexstar Media, Paramount Renew Affiliation Contracts
Jul 30, 2024
10:25 AM EDT, 07/30/2024 (MT Newswires) -- Nexstar Media Group ( NXST ) and Paramount Global ( PARAA ) said Tuesday that Nexstar and its Mission Broadcasting operating partner reached multi-year contracts to renew CBS Television Network affiliations in 42 markets throughout the US. Nexstar owns 40 stations, while Mission Broadcasting owns two, the companies said. Financial terms weren't disclosed....
Movano Evie Ring Could Soon Get FDA Clearance, Analyst Says: 'A Validated Wearable Device Truly Opens The Market'
Movano Evie Ring Could Soon Get FDA Clearance, Analyst Says: 'A Validated Wearable Device Truly Opens The Market'
Jul 30, 2024
Shares of Movano Inc ( MOVE ) have tanked more than 50% year to date. The FDA clearance of the company's Evie ring is expected this quarter, with a full commercial launch likely later this year, according to Benchmark. Analyst Bruce Jackson initiated coverage of with a Speculative Buy rating and price target of $2.00. The Movano Thesis: The company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved